Streetbeat News

Analyst Ratings

MRNA

Needham analyst Joseph Stringer has reiterated a Hold rating on Moderna (NASDAQ:MRNA).

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 10:46 am

RXST

Needham analyst David Saxon has reiterated a Buy rating on RxSight (NASDAQ:RXST) and maintained a price target of $66.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 10:40 am

FDX

Baird analyst Garrett Holland has reiterated an 'Outperform' rating for FedEx (NYSE:FDX) and maintained a price target of $340.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 10:37 am

RH

Baird analyst Peter Benedict maintains a Neutral rating on RH (NYSE:RH) and raises the price target from $275 to $290.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 10:36 am

HALO

HC Wainwright & Co. has reiterated its Buy rating for Halozyme Therapeutics, maintaining a price target of $65. Analyst Mitchell Kapoor continues to see potential in the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 10:36 am

CTMX

HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Neutral rating on CytomX Therapeutics (NASDAQ:CTMX).

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 10:34 am

TKO

Pivotal Research has initiated coverage on TKO Group Holdings with a Buy rating and set a price target of $170.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 10:30 am

RNAC

HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating for Cartesian Therapeutics (NASDAQ:RNAC) and maintained a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 10:28 am

AURA

HC Wainwright & Co. has reiterated its Buy rating on Aura Biosciences, maintaining a price target of $21. This suggests confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 10:25 am

FERG

Ferguson Enterprises Inc. (NYSE:FERG) is set to release its Q4 earnings on Sept. 17, with analysts expecting an increase in both earnings per share and revenue compared to the previous year. Several analysts have adjusted their price targets for FERG, with most maintaining positive ratings.

Portfolio Pulse from Avi Kapoor

September 13, 2024 | 10:17 am